Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irina Ganeeva

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|March 18, 2024
Asymmetric T-cell division: insights from cutting-edge experimental techniques and implications for immunotherapyYaroslav Kaminskiy, Irina Ganeeva, Vitaly Chasov, et al.
Biomedicines|January 13, 2021
Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral InfectionsEkaterina Zmievskaya, Aygul Valiullina, Irina Ganeeva, et al.
Biomolecules|January 8, 2025
Gut Microbiota Modulation: A Novel Strategy for Rheumatoid Arthritis TherapyVitaly Chasov, Elvina Gilyazova, Irina Ganeeva, et al.
Cells|August 9, 2024
Cell-Based Therapy and Genome Editing as Emerging Therapeutic Approaches to Treat Rheumatoid ArthritisVitaly Chasov, Irina Ganeeva, Ekaterina Zmievskaya, et al.
Bioengineering (Basel, Switzerland)|December 23, 2022
Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell ImmunotherapiesIrina Ganeeva, Ekaterina Zmievskaya, Aygul Valiullina, et al.
Journal of Biomedical Research|June 3, 2024
Systemic lupus erythematosus therapeutic strategy: From immunotherapy to gut microbiota modulationVitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, et al.
Frontiers in Immunology|September 6, 2021
Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based ImmunotherapiesVitaly Chasov, Mikhail Zaripov, Regina Mirgayazova, et al.
Molecular Biology Research Communications|May 5, 2025
The importance of <i>TP53</i> status in cancer therapy: The example of chronic lymphocytic leukemiaRegina Mirgayazova, Raniya Khadiullina, Elvina Gilyazova, et al.
Cancers|February 25, 2022
Knowns and Unknowns about CAR-T Cell DysfunctionAleksei Titov, Yaroslav Kaminskiy, Irina Ganeeva, et al.
Cancers|March 6, 2021
Adoptive Immunotherapy beyond CAR T-CellsAleksei Titov, Ekaterina Zmievskaya, Irina Ganeeva, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|March 18, 2024
Asymmetric T-cell division: insights from cutting-edge experimental techniques and implications for immunotherapyYaroslav Kaminskiy, Irina Ganeeva, Vitaly Chasov, et al.
Biomedicines|January 13, 2021
Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral InfectionsEkaterina Zmievskaya, Aygul Valiullina, Irina Ganeeva, et al.
Biomolecules|January 8, 2025
Gut Microbiota Modulation: A Novel Strategy for Rheumatoid Arthritis TherapyVitaly Chasov, Elvina Gilyazova, Irina Ganeeva, et al.
Cells|August 9, 2024
Cell-Based Therapy and Genome Editing as Emerging Therapeutic Approaches to Treat Rheumatoid ArthritisVitaly Chasov, Irina Ganeeva, Ekaterina Zmievskaya, et al.
Bioengineering (Basel, Switzerland)|December 23, 2022
Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell ImmunotherapiesIrina Ganeeva, Ekaterina Zmievskaya, Aygul Valiullina, et al.
Journal of Biomedical Research|June 3, 2024
Systemic lupus erythematosus therapeutic strategy: From immunotherapy to gut microbiota modulationVitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, et al.
Frontiers in Immunology|September 6, 2021
Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based ImmunotherapiesVitaly Chasov, Mikhail Zaripov, Regina Mirgayazova, et al.
Molecular Biology Research Communications|May 5, 2025
The importance of <i>TP53</i> status in cancer therapy: The example of chronic lymphocytic leukemiaRegina Mirgayazova, Raniya Khadiullina, Elvina Gilyazova, et al.
Cancers|February 25, 2022
Knowns and Unknowns about CAR-T Cell DysfunctionAleksei Titov, Yaroslav Kaminskiy, Irina Ganeeva, et al.
Cancers|March 6, 2021
Adoptive Immunotherapy beyond CAR T-CellsAleksei Titov, Ekaterina Zmievskaya, Irina Ganeeva, et al.
Pageof 2